Down-regulation of CD3zeta is a breast cancer biomarker associated with immune suppression.

about

Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer Context Specific and Differential Gene Co-expression Networks via Bayesian Biclustering Pathologic and gene expression features of metastatic melanomas to the brain

P2860

Q28266906-70F39D9D-C677-4B89-AA8C-5E45E8D05E91 Q28553187-04E5C1C5-EA73-47A1-A871-75862FD0BCEB Q37512029-2CF05D29-04AC-4EE8-AABC-2EC859C98CAB

P2860

Down-regulation of CD3zeta is a breast cancer biomarker associated with immune suppression.

Item

http://www.wikidata.org/entity/Q39649670

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Down-regulation of CD3zeta is ...... iated with immune suppression.

@en

Down-regulation of CD3zeta is ...... iated with immune suppression.

@nl

type

Item

label

Down-regulation of CD3zeta is ...... iated with immune suppression.

@en

Down-regulation of CD3zeta is ...... iated with immune suppression.

@nl

prefLabel

Down-regulation of CD3zeta is ...... iated with immune suppression.

@en

Down-regulation of CD3zeta is ...... iated with immune suppression.

@nl

P1476

Down-regulation of CD3zeta is ...... iated with immune suppression.

@en

P2093

Bin Yu

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression

Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.

Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer.

IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.

Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.

Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations

Understanding diagnostic tests 3: Receiver operating characteristic curves.

Antibody arrays--an emerging tool in cancer proteomics.

Immunobiological characterization of N -nitrosomethylurea-induced rat breast carcinomas: tumoral IL-10 expression as a possible immune escape mechanism.

The Youden Index and the optimal cut-point corrected for measurement error.

P304

165-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CBI20100346

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20883209

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Down-regulation of CD3zeta is a breast cancer biomarker associated with immune suppression.

about

P2860

P2860

Down-regulation of CD3zeta is a breast cancer biomarker associated with immune suppression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921